| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |